Zent O - Search Results

1

Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine.

Zent O, Hennig R. Zent O, et al. Vaccine. 2004 Dec 16;23(5):579-84. doi: 10.1016/j.vaccine.2004.07.016. Vaccine. 2004. PMID: 15542177

2

Immediate allergic reactions after vaccinations--a post-marketing surveillance review.

Zent O, Arras-Reiter C, Broeker M, Hennig R. Zent O, et al. Eur J Pediatr. 2002 Jan;161(1):21-5. doi: 10.1007/s00431-001-0853-0. Eur J Pediatr. 2002. PMID: 11808876 Review.

3

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults.

Zent O, Beran J, Jilg W, Mach T, Banzhoff A. Zent O, et al. Vaccine. 2003 Jan 30;21(7-8):738-41. doi: 10.1016/s0264-410x(02)00592-3. Vaccine. 2003. PMID: 12531352 Clinical Trial.

4

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.

Zent O, Banzhoff A, Hilbert AK, Meriste S, Słuzewski W, Wittermann Ch. Zent O, et al. Vaccine. 2003 Sep 8;21(25-26):3584-92. doi: 10.1016/s0264-410x(03)00421-3. Vaccine. 2003. PMID: 12922086 Clinical Trial.

5

Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule.

Zent O, Jilg W, Plentz A, Schwarz TF, Frühwein N, Kuhr HB, Banzhoff A. Zent O, et al. Vaccine. 2003 Dec 1;21(32):4655-60. doi: 10.1016/j.vaccine.2003.08.005. Vaccine. 2003. PMID: 14585672 Clinical Trial.

6

[New TBE vaccine formulations--free of proteineous stabilizer and preservatives. Overview of clinical studies and first year post-marketing experience].

Zent O, Wittermann Ch, Banzhoff A, Plentz A, Jilg W. Zent O, et al. MMW Fortschr Med. 2004 Jan 22;146(3-4):43. MMW Fortschr Med. 2004. PMID: 15035448 German. No abstract available.

7

TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.

Zent O, Schwarz TF, Plentz A, Banzhoff A, Jilg W. Zent O, et al. Int J Med Microbiol. 2004 Apr;293 Suppl 37:134-8. doi: 10.1016/s1433-1128(04)80024-x. Int J Med Microbiol. 2004. PMID: 15146995 Clinical Trial.

8

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?

Rendi-Wagner P, Kundi M, Zent O, Dvorak G, Jaehnig P, Holzmann H, Mikolasek A, Kollaritsch H. Rendi-Wagner P, et al. Among authors: zent o. Vaccine. 2004 Jul 29;22(21-22):2743-9. doi: 10.1016/j.vaccine.2004.01.041. Vaccine. 2004. PMID: 15246606 Clinical Trial.

9

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?

Zent O, Plentz A, Schwarz TF, Frühwein N, Kuhr HB, Broeker M, Banzhoff A, Jilg W. Zent O, et al. Vaccine. 2004 Dec 2;23(3):312-5. doi: 10.1016/j.vaccine.2004.06.007. Vaccine. 2004. PMID: 15530673 Clinical Trial.

10

Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers.

Zent O, Hennig R, Banzhoff A, Bröker M. Zent O, et al. J Travel Med. 2005 Mar-Apr;12(2):85-93. doi: 10.2310/7060.2005.12205. J Travel Med. 2005. PMID: 15996453 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters